Skip to main content

Xunlei Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2025

SHENZHEN, China, Nov. 13, 2025 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading technology company providing distributed cloud services in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights:Total revenues were US$126.4 million, representing an increase of 57.7% year-over-year.Subscription revenues were US$40.7 million, representing an increase of 22.3% year-over-year.Live-streaming and other services revenues were US$49.1 million, representing an increase of 127.1% year-over-year.Cloud computing revenues were US$36.6 million, representing an increase of 44.9% year-over-year.Gross profit was US$60.5 million, representing an increase of 49.6% year-over-year, and...

Continue reading

JD.com Announces Third Quarter 2025 Results

BEIJING, Nov. 13, 2025 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the “Company” or “JD.com”), a leading supply chain-based technology and service provider, today announced its unaudited financial results for the three months ended September 30, 2025. Third Quarter 2025 HighlightsNet revenues were RMB299.1 billion (US$142.0 billion) for the third quarter of 2025, an increase of 14.9% from the third quarter of 2024. Net income attributable to the Company’s ordinary shareholders was RMB5.3 billion (US$0.7 billion) for the third quarter of 2025, compared to RMB11.7 billion for the third quarter of 2024. Non-GAAP2 net income attributable to the Company’s ordinary shareholders was RMB5.8 billion (US$0.8 billion) for the third quarter of 2025, compared to RMB13.2 billion for the...

Continue reading

Endeavour Reports Strong Q3-2025 Results

ENDEAVOUR REPORTS STRONG Q3-2025 RESULTSYTD-2025 production of 911koz at AISC of $1,362/oz • FY-2025 guidance on track • YTD-2025 free cash flow of $680mOPERATIONAL AND FINANCIAL HIGHLIGHTSYTD-2025 production of 911koz, on track for the top half of the guidance range; Q3-2025 production of 264koz.YTD-2025 AISC of $1,362/oz, on track for the guidance range; impacted by +$103/oz of gold price driven royalty costs compared to guidance; Q3-2025 AISC of $1,569/oz; impacted by +$131/oz of gold price driven royalty costs.Adj. EBITDA of $1,634m YTD-2025, up +110% over YTD-2024; $466m for Q3-2025.Adj. Net Earnings of $556m (or $2.29/sh) YTD-2025, up +375% over YTD-2024; $159m (or $0.66/sh) for Q3-2025.FCF of $680m ($746/oz produced) YTD-2025, up +1,411% over YTD-2024; $166m ($629/oz produced) for Q3-2025.Gross...

Continue reading

Cornish Metals Releases Unaudited Financial Statements and Management’s Discussion and Analysis for the Nine Months Ended 30 September 2025

VANCOUVER, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSXV: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its wholly owned and permitted South Crofty tin project in Cornwall, United Kingdom, is pleased to announce that it has released its unaudited financial statements and management, discussion and analysis (“MD&A”) for the nine months ended September 30, 2025. The reports are available under the Company’s profile on SEDAR+ (www.sedarplus.ca) and on the Company’s website (www.cornishmetals.com). Highlights for the nine months ended September 30, 2025 and for the period ending November 12, 2025 (All figures expressed in Canadian dollars unless otherwise stated)Updated South Crofty Preliminary Economic Assessment (“PEA”) (news...

Continue reading

Zealand Pharma Announces Financial Results for the First Nine Months of 2025

Company announcement – No. 23 / 2025 Zealand Pharma Announces Financial Results for the First Nine Months of 2025With petrelintide advancing at full speed and topline data rapidly approaching for both petrelintide and survodutide, upcoming Capital Markets Day will set the stage for a catalyst-rich 2026.Achieved key milestone in the petrelintide Phase 2 ZUPREME-1 trial in people with overweight and obesity, with the last participant completing the 28-week primary endpoint visit, paving the way for 42-week topline data in H1 2026. Approaching Phase 3 data in H1 2026 with survodutide, following last participant last visit in the 76-week SYNCHRONIZETM-1 trial in people with overweight and obesity without type 2 diabetes. Zealand Pharma is excited to outline a catalyst-rich 2026 at its upcoming Capital Markets Day on December 11, highlighting...

Continue reading

NORBIT – Results for the third quarter of 2025

Trondheim, 13 November 2025: In the third quarter, NORBIT delivered revenues of NOK 505.4 million, an increase of 36 per cent compared to the corresponding quarter of 2024. The reported EBIT result was NOK 75.4 million, representing a margin of 15 per cent. For the first nine months of the year, NORBIT delivered revenues of NOK 1 711.5 million, up 43 per cent from the same period last year, while the EBIT result was NOK 377.0 million, up 92 per cent from the corresponding period of 2024.The Oceans segment reported revenues of NOK 192.4 million, a 22 per cent increase from the third quarter of 2024, driven by strong sonar sales. The EBIT margin for the segment was 21 per cent. The Connectivity segment reported revenues of NOK 107.5 million, a decline of 3 per cent, and an EBIT margin of 15 per cent. The decline was due to lower deliveries...

Continue reading

Trading update Q3 2025: another record year taking shape

Highlights third quarter 2025Group nine-month turnover surpassed 3 billion euros, a 3% increase year-over-year Order book is 7.5 billion euros, compared to 7.1 billion euros last year Management reiterates its expectations that full-year turnover will be at least in line with 2024 and forecasts a strong year-over-year EBITDA improvement, with the EBITDA margin in the range of 20% to 22% DEME took delivery of its new offshore installation vessel Norse Wind in October, completed on schedule, and set to commence operations in the first half of 2026AttachmentP2025 DEME Trading update Q3 2025 ENG

Continue reading

Banqup delivers 21% organic subscription revenue growth and operational momentum in 9M 2025

 PRESS RELEASE – REGULATED INFORMATION   La Hulpe, Belgium – 13 November 2025, 7:00 a.m. CET – REGULATED INFORMATION – Banqup Group SA, formerly Unifiedpost Group SA, (Euronext: BANQ) (Banqup, Company), a leading provider of integrated business communications solutions, publishes its business update for the nine months of 2025. 9M 2025 Financial HighlightsSolid organic subscription revenue growth of +21,2% y/y Digital service revenue (including income from client money) growth of +5,0% y/y driven by subscription and transaction revenue growthStrategic & Operational HighlightsIncreasing momentum in Belgium, with onboarding activities accelerating in advance of the 1 January 2026  e-invoicing mandate. Successfully signed partnerships with Deloitte Belgium, Rentio and other Belgian accounting firms, with additional...

Continue reading

Multitude delivers strong profitability growth and continued operational progress in 9M 2025

Zug, 13 November 2025 – Multitude AG, a listed European FinTech company, offering digital lending and online banking services to consumers, small and medium-sized enterprises, and other FinTechs (WKN: A40VJN, ISIN: CH1398992755) (“Multitude”, “Company” or “Group”) has published its figures for the first nine months of 2025, which continues to show positive developments in all business units: Consumer Banking (Ferratum), SME Banking (CapitalBox), and Wholesale Banking (Multitude Bank).Key figures, EUR million 9M 2025 9M 2024 % changeRevenue 195.9 193.9 1.0Interest income 186.6 193.9 (3.8)Net interest income 153.3 163.8 (6.4)Net fee and commission income 7.9 0.1 –Profit for the period 20.3 12.8 59.3Against economic and political uncertainties, Multitude has delivered a significant increase in profitability on...

Continue reading

Discovery Reports 63,154 Ounces Of Gold Production, $86.8 Million Of Free Cash Flow(1) In Q3 2025

Cash of $341.5 million at September 30, 2025Q3 2025 NET EARNINGS AND EPSNet earnings of $42.4M ($0.05/share) versus net loss of $3.9M ($0.01/share) in Q3 2024; Adjusted net earnings1 totaled $61.1 million or $0.08/share.GOLD PRODUCTION IN Q3 202563,154 oz produced compared to 50,552 oz in Q2 2025 (from April 16 – June 30).OPERATING CASH COSTS IN LINE WITH EXPECTATIONSOperating cash costs1 of $1,339/oz sold versus $1,341/oz in Q2 2025.ATTRACTIVE MARGINS DRIVE PROFITABILITY AND CASH FLOWAll-in sustaining costs (“AISC”)1 averaged $1,734/oz sold compared to an average realized gold price1 of $3,489/oz; Site-level AISC2 averaged $1,699/oz sold.STRONG CASH FLOW FROM GOLD SALES Net cash from operating activities of $153.5M; Free cash flow1 of $86.8M.SOLID CASH POSITION TO SUPPORT OPERATIONS AND GROWTH PLANSCash at...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.